Induction of apoptosis by death receptors such as Fas or tumour necrosis factor (TNF) R1 leads to distinct changes in cell morphology, activation of the caspase protease cascade, and the degradation of nuclear chromatin by activated nucleases. Here, we describe the purification and cDNA cloning of a novel 40 kDa endonuclease from Jurkat cells that is activated by caspases. This protein, designated caspase-activated nuclease (CPAN), is sufficient to degrade naked DNA and to induce apoptotic morphology and DNA fragmentation in naive nuclei. CPAN is highly homologous to a recently described mouse nuclease, CAD 
Results and discussion
We have developed an in vitro apoptosis system that mimics the later stages of the apoptotic cascade under cellfree conditions. Addition of apoptotic cell extracts to naive Jurkat nuclei induced chromatin condensation and the formation of an internucleosomal DNA 'ladder' detected by agarose gel electrophoresis. To study nuclease activation in vitro, we added recombinant caspase-3 to normal Jurkat cytosol and then measured DNA fragmentation in the in vitro apoptosis assay and in a standard nuclease assay with protein-free (naked) DNA. Addition of caspase-3 alone (Figure 1a, lane 1) or Jurkat cell cytosol alone ( Figure 1a , lane 2) to naive Jurkat nuclei did not induce DNA fragmentation. When caspase-3 was added to cytosol, however, substantial DNA fragmentation was observed ( Figure 1a, lane 3) . When the same experiment was repeated using naked human DNA instead of nuclei, a similar result was obtained: addition of caspase-3 to cytosol resulted in the apparent activation of an endonuclease to degrade human DNA ( Figure 1a , lane 8). These results suggest that an inactive endonuclease present in cytosol is activated by caspase-3 to degrade nuclear chromatin or naked DNA in vitro. We have named the activated endonuclease caspase-activated nuclease, or CPAN.
To identify the active nuclease in cytosol, we fractionated cytosol from 65 litres of Jurkat cells using a four-step procedure. On the final gel filtration column, activated CPAN eluted as a single peak of nuclease activity (Figure 1b) that correlated with the intensity of a 40 kDa band (Figure 1c ) resolved by SDS-PAGE. Using sequence data derived from CPAN peptides, we isolated a full-length cDNA clone (Figure 2a ) encoding a 39,078 dalton protein containing all seven peptide sequences determined from the native protein. CPAN has no significant homology to known nuclease protein families [3] and may, therefore, represent a new class of endonuclease. CPAN is highly homologous to the recently described mouse nuclease CAD [1] and probably represents the human homologue. Although the amino-acid sequences of human CPAN and the reported mouse CAD are quite similar (71% identical), there is a striking difference over 30 amino acids in the central region of the sequences (Figure 2a ). Peptide sequencing of native CPAN across this region (peptide III) confirms that the encoded protein sequence in the CPAN cDNA is correct. To determine whether the reported mouse CAD cDNA was also correct, we amplified the segment of the mouse gene in the region of the discrepancy (nucleotides 80-280 in mouse CAD cDNA) using five different tissue sources. In all five cases, the products were identical but differed from the published sequence by the deletion of three thymidine nucleotides (Figure 2b ). The amino-acid sequence predicted when these nucleotides are deleted is 72% identical to the human CPAN sequence in this region, whereas the published sequence was only 7% identical ( Figure 2c ). It seems likely that the published amino-acid sequence for mouse CAD [1] is incorrect between residues 46-75.
Recently, a protein complex known as DFF (DNA fragmentation factor) was described [2] with biochemical activity similar to CPAN. DFF is an 80 kDa protein complex comprising 40 kDa (DFF40) and 45 kDa (DFF45) components. The cDNA for DFF45, but not for DFF40, was reported. Our results suggest that CPAN may be DFF40. First, inactive CPAN complex has an apparent molecular weight similar to DFF. Second, CPAN is activated by caspase-3 treatment but does not contain any predicted caspase cleavage sites. We hypothesized that CPAN is maintained in an inactive state by binding to DFF45. Cleavage of DFF45 by caspases then releases DFF45 and activates CPAN as an endonuclease.
To examine whether CPAN alone is an active nuclease and whether it associates with DFF45, we expressed CPAN and The specific activity of recombinant CPAN (1.2 × 10 6 U/mg) was similar to that of the purified native CPAN when tested in the in vitro apoptosis assay. In a spectrophotometric Kunitz assay [4] , CPAN was shown to have approximately equivalent specific activity (2.5 × 10 8 U/mg) to that of bovine pancreatic DNase I [4] . The biochemical characteristics of the poly(U)-purified CPAN were analyzed in a nuclease assay. CPAN was Brief Communication 539 found to be significantly less active when assayed in the absence of the carrier protein bovine serum albumin (BSA) and salt (Figure 3c ). CPAN was also found to be magnesium or manganese dependent and inhibited by zinc and aurintricarboxylic acid (ATA), but not by globular actin.
The results presented here demonstrate that CPAN associates with DFF45 in an inactive nuclease complex that is similar to the native DFF complex, suggesting that CPAN may be equivalent to DFF40. However, activated native DFF was reported to be inactive as a nuclease when tested on naked DNA [2] . We have shown that the nuclease activity of CPAN required the presence of magnesium ions, sodium chloride, and a carrier protein such as BSA. When native DFF was tested for nuclease activity, the assay conditions involved low levels of magnesium ions and salt with no BSA added. Such conditions could significantly reduce the apparent nuclease activity of DFF to less than detectable levels.
In this report, we describe the discovery of a human endonuclease activated in apoptosis by the proteolytic action of caspases. Through its association with the caspasesensitive inhibitor DFF45, CPAN activation is dependent on the activation of the cysteine protease cascade. Inhibitors of apoptotic cell death have been shown to block apoptosis through the inhibition of caspases [5, 6] . Once caspases have activated CPAN, however, these inhibitors can no longer block the fragmentation of genomic DNA as the nuclease activity of CPAN is unaffected. Therefore, CPAN activation represents a critical event that occurs downstream of caspases and results in the destruction of nuclear chromatin, the hallmark of the apoptotic program.
Materials and methods
Assay for CPAN activity CPAN activity was determined using an in vitro apoptosis assay or a nuclease assay. Fractions containing inactive CPAN were incubated with caspase-3 (25 ng) for 30 min at 25°C in 20 µl of buffer A (10 mM Hepes pH 7.4, 50 mM sodium chloride, 2 mM MgCl 2 , 5 mM EGTA, 1 mM DTT) containing 0.83 mM ATP, 8.3 mM creatine phosphate, 33.2µg/ml creatine kinase. Naive Jurkat nuclei (5 µl, 6.5 × 10 5 total), prepared essentially as described in [7] , were added and incubated for 1-2 h at 37°C. The percentage of apoptotic nuclei was determined microscopically using Hoechst 33258 stain. DNA fragmentation was determined by extraction of genomic DNA [8] and analysis by 1% agarose gel electrophoresis visualized with ethidium bromide. For measuring nuclease activity, activated fractions were incubated in buffer (10 µl, 10 mM Hepes pH 7.4, 4 mM MgCl 2 , 4 mM DTT, 5 mM EGTA, 1 mg/ml BSA and 75 mM sodium chloride) with human genomic DNA (1 µg, Promega), incubated for 1-2 h at 30°C, and then analyzed by 1% agarose gel electrophoresis.
cDNA cloning and expression of CPAN and DFF45
Degenerate oligonucleotide primers 5′-GCNTTYCAYGARCCICAR-GTIGG-3′ and 5′-TGIGGIGCYTGYTCRTCRCA-3′ designed from the sequence of CPAN peptide IV were used to amplify a 72 bp nucleotide fragment of CPAN by PCR from a placenta cDNA library (Clontech Marathon-Ready). Based on this sequence, nested PCR was performed using the same placenta cDNA library. A 400 bp fragment was obtained, labeled with 32 P using an Amersham Rediprime kit, and used to screen 3 × 10 6 clones of a bone-marrow library prepared in a ZapExpress II λgt10 phage (Stratagene) plated on XL1-MRF′ Blue cells. Two clones were identified, one of which (clone 11) was full length (3.3 kb) encoding the amino-terminal sequence of CPAN. DNA sequence analysis of clone 11 revealed that the CPAN open reading frame was interrupted by two insertions that introduced two frameshifts and a stop codon. To identify a complete CPAN clone lacking insertions, the primers 5′-GCGAGGACGGATCTGAGCAGCTGGGCAG-3′ and 5′-AAATGATGCCCACGTCAGGCCTCAAACA-3′ were used to amplify the CPAN coding region by PCR from human leukocyte and HeLa cDNA libraries (Clontech) and from first-strand cDNA reverse-transcribed from oligo(dT)-primed total human pancreas RNA (Clontech). Full-length CPAN cDNA (GenBank accession number AF039210) from pancreas was PCR amplified using primers that included a KT3 tag in-frame at the carboxyl terminus of the CPAN sequence. The KT3-tagged CPAN insert was subcloned into the pFASTBAC donor plasmid (GIBCO BRL).
The full-length DFF45 cDNA was PCR amplified from a human liver cDNA library (Gibco, BRL) with an in-frame Glu tag at the carboxyl terminus and a His 6 tag at the amino terminus. The His 6 -Glu-tagged DFF45 baculovirus was generated via the BacPAK-His2 transfer vector (Clontech). Recombinant protein was obtained from suspension cultures of 1.5 × 10 6 Sf9 cells per ml infected at a multiplicity of infection of 1-5 for 72 h at 25°C in serum-free media.
cDNA cloning of murine CAD
The sequence of murine CAD was verified from three independent RNA sources, thymus (CD1 mouse), spleen (BALB/c mouse; Clontech), and L-929 cells (C3H mouse), and from two cDNA library sources, brain (BALB/c; Clontech) and 14 day embryo (CD1 mouse). RNA was reverse transcribed using an oligo(dT) primer and the Gene Amp RNA PCR kit (Perkin Elmer) according to manufacturer's instructions. Products from the reverse transcription reaction and mouse libraries were PCR amplified using the primers 5′-TTGCGAGCCCTACATAGC-3′ and 5′-CAGTAG-GTCCGACGTGCC-3′ and then sequenced directly in both directions.
Supplementary material
Additional methodological details are available as Supplementary material published with this article on the internet.
